crisnatol has been researched along with Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cobb, P; Drengler, R; Eckhardt, SG; Kraynak, M; Kuhn, J; Petit, T; Rowinsky, EK; Santabarbara, P; Simmons, C; Villalona-Calero, MA; Von Hoff, DD | 1 |
Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR | 1 |
Cobb, PW; Craig, JB; Harman, GS; Havlin, KA; Koeller, J; Kuhn, JG; Luther, JS; Turner, JN; Tweedy, DA; Weiss, GR | 1 |
Baker, LH; Chabot, GG; Lucas, S; Poplin, EA; Tuttle, RL; Wargin, WA | 1 |
Craig, JB; Harman, GS; Koeller, J; Kuhn, JG; Lucas, VS; Luther, JS; Turner, JN; Tuttle, RL; Tweedy, DA; Weiss, GR | 1 |
1 review(s) available for crisnatol and Neoplasms
Article | Year |
---|---|
New anticancer agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate | 1991 |
3 trial(s) available for crisnatol and Neoplasms
Article | Year |
---|---|
A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Chrysenes; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Propylene Glycols; Pulmonary Embolism; Thrombocytopenia | 1999 |
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule.
Topics: Aged; Antineoplastic Agents; Chrysenes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Nervous System Diseases; Propylene Glycols | 1991 |
Crisnatol mesylate: phase I dose escalation by extending infusion duration.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Chrysenes; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Propylene Glycols; Sarcoma | 1991 |
1 other study(ies) available for crisnatol and Neoplasms
Article | Year |
---|---|
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule.
Topics: Adult; Aged; Antineoplastic Agents; Arrhythmias, Cardiac; Blood Pressure; Chrysenes; Digestive System; Drug Administration Schedule; Drug Evaluation; Electroencephalography; Female; Humans; Male; Middle Aged; Neoplasms; Nervous System; Phenanthrenes; Propylene Glycols | 1988 |